Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples